UnitedHealth Group (NYSE:UNH) Stock Falls 1.7% – Time to Sell?

UnitedHealth Group Incorporated (NYSE:UNH) was down 1.7% on Friday. The company traded as low as $416.37 and last traded at $417.9670. 3,885,552 shares traded hands during trading, a decline of 47% from the average daily volume of 7,335,360 shares. The stock had previously closed at $424.98.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Third-quarter beat and raised outlook support the shares. Adjusted EPS rose approximately 61% to $4.69, exceeding the $4.14 consensus estimate, while revenue reached $112.7 billion versus expectations of $111.3 billion. Management raised its 2026 adjusted EPS outlook to at least $20.50, reinforcing investor confidence in its cost controls and execution. UnitedHealth beat-and-raise quarter
• Positive Sentiment: Optum Health’s performance improved materially. The unit’s profit increased to $735 million, helping demonstrate operating leverage and contributing to UnitedHealth’s post-earnings recovery. Optum Health profit surge
• Positive Sentiment: Analyst expectations and valuation support remain favorable. Erste Group raised its FY2026 EPS estimate to $20.55 from $19.86 and its FY2027 estimate to $23.29 from $22.51. Mizuho also lifted its price target to $500 from $493 and maintained an “outperform” rating, implying additional upside from the referenced price. Mizuho raises UnitedHealth price target
• Neutral Sentiment: Investor attention and value-based coverage may increase trading interest. Zacks highlighted heightened investor attention and characterized UNH as a value stock, but these are sentiment and screening signals rather than new fundamental developments. Zacks value-stock analysis
• Negative Sentiment: Higher 2027 Medicare costs could pressure affordability and margins. The planned increase in costs for seniors may create political and utilization concerns, potentially offsetting some of the recent earnings momentum. Healthcare stocks also faced broader sector pressure in recent trading. UnitedHealth 2027 Medicare costs

Analysts Set New Price Targets

UNH has been the subject of a number of recent research reports. Oppenheimer increased their target price on UnitedHealth Group from $420.00 to $500.00 and gave the stock an “outperform” rating in a report on Friday, July 17th. Royal Bank Of Canada upped their price target on UnitedHealth Group from $478.00 to $498.00 and gave the company an “outperform” rating in a research report on Tuesday. Weiss Ratings upgraded UnitedHealth Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, October 8th. Cantor Fitzgerald boosted their target price on shares of UnitedHealth Group from $440.00 to $495.00 and gave the company an “overweight” rating in a research note on Friday, July 17th. Finally, Barclays lowered their target price on shares of UnitedHealth Group from $441.00 to $440.00 and set an “overweight” rating on the stock in a report on Wednesday, October 14th. Twenty equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $463.80.

UnitedHealth Group Stock Down 1.7%

The firm’s 50-day moving average is $388.15 and its two-hundred day moving average is $389.52. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.74. The stock has a market cap of $375.16 billion, a P/E ratio of 23.87, a PEG ratio of 1.51 and a beta of 0.60.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, topping analysts’ consensus estimates of $4.14 by $0.55. The company had revenue of $112.70 billion during the quarter, compared to the consensus estimate of $111.31 billion. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The firm’s quarterly revenue was down .4% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 20.64 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were given a dividend of $2.32 per share. The ex-dividend date was Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a yield of 2.2%. UnitedHealth Group’s dividend payout ratio is presently 53.00%.

Insider Activity

In other news, CEO Patrick Conway sold 1,169 shares of the firm’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the transaction, the chief executive officer owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.19% of the company’s stock.

Hedge Funds Weigh In On UnitedHealth Group

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. NTV Asset Management LLC acquired a new stake in shares of UnitedHealth Group during the third quarter worth about $217,000. Sowell Financial Services LLC increased its stake in UnitedHealth Group by 12.5% during the 3rd quarter. Sowell Financial Services LLC now owns 6,621 shares of the healthcare conglomerate’s stock worth $2,430,000 after purchasing an additional 738 shares in the last quarter. Evergreen Capital Management LLC raised its holdings in UnitedHealth Group by 1.4% during the 3rd quarter. Evergreen Capital Management LLC now owns 21,340 shares of the healthcare conglomerate’s stock worth $7,833,000 after buying an additional 303 shares during the period. Nabity Jensen Investment Management Inc raised its holdings in UnitedHealth Group by 6.7% during the 3rd quarter. Nabity Jensen Investment Management Inc now owns 1,869 shares of the healthcare conglomerate’s stock worth $686,000 after buying an additional 117 shares during the period. Finally, Gibbs Wealth Management lifted its stake in UnitedHealth Group by 40.5% in the third quarter. Gibbs Wealth Management now owns 1,806 shares of the healthcare conglomerate’s stock valued at $663,000 after buying an additional 521 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.